Vector(s) containing an inducible gene encoding a cell cycle regulator useful for treating neurodegenerative disorders

The present invention provides a vector containing a gene useful for treating neurodegenerative disorders, especially Alzheimer’s disease. These vectors can be used in therapeutic applications to prevent neurodegenerative disorders or to slow down their progression with therapeutic efficacy. The invention comprises a gene therapeutic approach based on neuron-specific targeting of cell cycle activation and progression.

pending patent: EP2218784A1 and US20120004277A1

Further Information: PDF

GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120

Contact
Beate-Victoria Ermisch

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

High-energy-density aqueous battery based on halogen multi-electron transfer

Traditional non-aqueous lithium-ion batteries have a high energy density, but their safety is compromised due to the flammable organic electrolytes they utilize. Aqueous batteries use water as the solvent for…

First-ever combined heart pump and pig kidney transplant

…gives new hope to patient with terminal illness. Surgeons at NYU Langone Health performed the first-ever combined mechanical heart pump and gene-edited pig kidney transplant surgery in a 54-year-old woman…

Biophysics: Testing how well biomarkers work

LMU researchers have developed a method to determine how reliably target proteins can be labeled using super-resolution fluorescence microscopy. Modern microscopy techniques make it possible to examine the inner workings…

Partners & Sponsors